Natalizumab LC46-58 KGN deimmunised
LLIHYTKGNQPGI-acid
Description
Application Data
Description
-
Natalizumab LC46-58 KGN deimmunised
Application Data
-
Catalogue number crb1001727 Molecular Weight 1452.8 Sequence (one letter code) LLIHYTKGNQPGI-acid
Sequence (three letter code) H-Leu-Leu-Ile-His-Tyr-Thr-Lys-Gly-Asn-Gln-Pro-Gly-Ile-OH
Purity >95% Manufactured in: United Kingdom Natalizumab LC46-58 KGN deimmunised